Immediate release carbidopa/levodopa

DRUG2 trials

Sponsors

Novartis Pharmaceuticals, Novartis

Conditions

Parkinson's Disease

Phase 3

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

CompletedNCT00099268

Novartis PharmaceuticalsParkinson's Disease

Start: 2004-09-30End: 2008-11-30Updated: 2012-04-23

Phase 4

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

TerminatedNCT00642356

NovartisParkinson's Disease

Start: 2008-03-31End: 2009-05-31Updated: 2011-02-18